Jul 29, 2015 at 11:18 | Source: Moneycontrol.com
According to Ajay Jain, CEO at asromoneyguru.com, combination of Mars with Saturn may attract volatility in Indian stock market.
Jul 28, 2015 at 13:21 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2015, to consider and take on record the Unaudited Financial Results of the Company for the first quarter and three months ended June 30, 2015.
Jul 28, 2015 at 10:00 | Source: CNBC-TV18
HSBC's Jitendra Sriram, says Maruti Suzuki can post a decent upside from its current levels. A weaker yen and its foray into other interesting space will take the stock to Rs 6000 levels in the next two years, he adds.
Jul 28, 2015 at 08:13 | Source: CNBC-TV18
Tech Mahindra | Ambuja Cements | Bank of India | Trident | Venky | Maharashtra Scooters | Supreme Industries | Electrosteel Steels | Axis Bank | Just Dial | KEC International | Torrent Pharma and Jagran Prakashan are stocks, which are in the news today.
Jul 28, 2015 at 07:49 | Source: Reuters
The Dow Jones industrial average finished at its lowest level since February, and the S&P 500 chalked up a five-session losing streak for the first time since January.
Jul 27, 2015 at 16:42 | Source: Moneycontrol.com
IDFC, Tata Motors DVR and HCL Infosystems were the top sells, while Tata Motors, Kotak Mahindra Bank and Sun Pharmaceutical were the top buys.
Jul 27, 2015 at 13:08 | Source: CNBC-TV18
Dipan Mehta - member at BSE & NSE maintains overweight position on pharma as well as private sector banks.
Jul 27, 2015 at 12:46 | Source: CNBC-TV18
In an interview with CNBC-TV18, Dipan Mehta, member of BSE and NSE said that he is bullish on mid cap pharma companies, private banks and NBFCs.
Jul 27, 2015 at 12:33 | Source: CNBC-TV18
Dipan Mehta - member at BSE & NSE is of the view that one may look at exiting Sun Pharma, Tata Motors and Lupin on every rise.
Jul 27, 2015 at 11:26 | Source: Reuters
Jerusalem-based Teva, which has offered to buy Mylan for USD 40 billion, is now close to an agreement to acquire Dublin-based Allergan's generic drugs unit for between USD 40 billion and USD 45 billion, the person said on Saturday.